Double maintains 4 strategies that include CRSP - CRISPR Therapeutics AG
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
ARKG | 77.82% | $936.86M | 0.75% |
GNOM | 70.66% | $47.13M | 0.5% |
ARKK | 66.01% | $5.03B | 0.75% |
XBI | 63.78% | $4.76B | 0.35% |
CPRJ | 63.66% | $48.38M | 0.69% |
KOMP | 58.53% | $1.95B | 0.2% |
IBB | 57.33% | $5.61B | 0.45% |
IBUY | 57.20% | $154.71M | 0.65% |
CWB | 56.96% | $3.78B | 0.4% |
IWC | 56.91% | $797.08M | 0.6% |
IWO | 56.86% | $10.72B | 0.24% |
QCLN | 56.37% | $399.59M | 0.59% |
VBK | 56.35% | $17.32B | 0.07% |
QQQJ | 56.30% | $592.09M | 0.15% |
ROBT | 56.10% | $420.42M | 0.65% |
PBW | 55.80% | $213.72M | 0.65% |
QQA | 55.49% | $187.77M | 0% |
SPHB | 55.14% | $336.39M | 0.25% |
BUZZ | 55.03% | $48.67M | 0.76% |
IWM | 55.03% | $62.65B | 0.19% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -57.17% | $416.76M | 1.43% |
VIXY | -32.89% | $195.31M | 0.85% |
TAIL | -26.71% | $87.65M | 0.59% |
USDU | -16.97% | $206.96M | 0.5% |
UUP | -16.52% | $325.79M | 0.77% |
CTA | -13.80% | $978.30M | 0.76% |
UGA | -12.21% | $87.23M | 0.97% |
CCOR | -12.07% | $64.12M | 1.18% |
DBO | -9.35% | $202.41M | 0.77% |
USO | -8.93% | $972.70M | 0.6% |
BNO | -8.87% | $99.25M | 1% |
DBE | -7.79% | $55.52M | 0.77% |
USL | -7.19% | $47.77M | 0.85% |
TBIL | -7.11% | $5.39B | 0.15% |
OILK | -7.08% | $67.85M | 0.69% |
BILZ | -6.28% | $734.41M | 0.14% |
IYK | -5.08% | $1.53B | 0.4% |
ULST | -3.46% | $585.14M | 0.2% |
KMLM | -3.33% | $218.49M | 0.9% |
COMT | -3.27% | $684.20M | 0.48% |
Finnhub
ZUG, Switzerland and BOSTON, April 03, 2025 -- CRISPR Therapeutics , a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that...
Finnhub
ZUG, Switzerland and BOSTON, March 26, 2025 -- CRISPR Therapeutics , a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that...
SeekingAlpha
CRISPR Therapeutics poised for growth with international potential and clinical assets. Read why I rate CRSP stock a Strong Buy right now.
SeekingAlpha
Moderate risks and strong fundamentals make high-return strategies of selling put options on Intel and CRISPR attractive. Read an analysis here.
SeekingAlpha
CRISPR Therapeutics' stock faces challenges with slow Casgevy adoption and competition. See how CRSP stock remains a cautious "Hold" within a barbell portfolio.
SeekingAlpha
CRISPR Therapeutics AG (NASDAQ:CRSP) TD Cowen 45th Annual Healthcare Conference March 3, 2025 10:30 AM ETCompany ParticipantsSamarth Kulkarni -...
Current Value
$32.511 Year Return
Current Value
$32.511 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
INGR | -0.06% | $8.69B | +18.28% | 2.34% |
RLI | 0.07% | $7.41B | +12.56% | 1.25% |
LRN | 0.10% | $5.71B | +112.31% | 0.00% |
COKE | -0.10% | $12.20B | +72.27% | 0.44% |
AEE | 0.15% | $27.24B | +37.85% | 2.66% |
BG | 0.24% | $10.45B | -24.81% | 3.49% |
TW | -0.26% | $31.68B | +48.00% | 0.28% |
AON | -0.28% | $85.54B | +22.05% | 0.68% |
ETR | -0.33% | $37.31B | +65.92% | 4.73% |
ICFI | -0.37% | $1.59B | -41.46% | 0.67% |
KMB | -0.44% | $47.39B | +13.36% | 3.37% |
RTX | 0.47% | $177.77B | +36.49% | 1.91% |
PRA | 0.64% | $1.20B | +85.99% | 0.00% |
IMNN | 0.66% | $15.35M | -24.46% | 0.00% |
NEXA | 0.69% | $819.80M | -15.55% | 0.00% |
TTE | 0.69% | $135.10B | -10.80% | 5.37% |
NOMD | -0.74% | $3.02B | +4.08% | 3.10% |
PPC | 0.75% | $11.62B | +59.32% | 0.00% |
FIZZ | -0.78% | $3.90B | -9.84% | 0.00% |
CORT | -0.82% | $8.84B | +226.74% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XLP | -0.11% | $16.87B | 0.09% |
GBIL | 0.12% | $6.30B | 0.12% |
JAAA | -0.16% | $21.29B | 0.21% |
XHLF | -0.23% | $1.06B | 0.03% |
IVOL | -0.26% | $476.36M | 1.02% |
PDBC | 0.28% | $4.89B | 0.59% |
BIL | -0.29% | $41.88B | 0.1356% |
TBLL | 0.69% | $2.13B | 0.08% |
AGZD | -0.72% | $134.05M | 0.23% |
DBC | 0.82% | $1.36B | 0.87% |
WEAT | -1.33% | $115.75M | 0.28% |
USCI | -1.48% | $240.82M | 1.07% |
TPMN | -1.66% | $33.32M | 0.65% |
GSG | -1.98% | $1.05B | 0.75% |
AGGH | 2.23% | $317.82M | 0.29% |
EQLS | 2.24% | $4.80M | 1% |
SGOV | 2.37% | $39.98B | 0.09% |
FTXG | -2.43% | $26.06M | 0.6% |
CLOI | 2.43% | $1.01B | 0.4% |
SHV | 2.77% | $20.16B | 0.15% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BEAM | 72.28% | $1.85B | -37.74% | 0.00% |
RXRX | 69.06% | $2.13B | -40.76% | 0.00% |
NTLA | 65.22% | $755.67M | -70.78% | 0.00% |
ALLO | 59.09% | $312.86M | -64.79% | 0.00% |
ABCL | 57.66% | $661.53M | -49.32% | 0.00% |
OPEN | 53.62% | $730.75M | -64.81% | 0.00% |
CRBU | 53.23% | $80.08M | -81.60% | 0.00% |
DNLI | 51.95% | $2.00B | -29.07% | 0.00% |
FATE | 51.73% | $88.24M | -89.02% | 0.00% |
RCKT | 51.23% | $671.77M | -75.23% | 0.00% |
VSH | 51.05% | $2.16B | -28.21% | 2.94% |
TWST | 51.04% | $2.28B | +14.61% | 0.00% |
KN | 49.66% | $1.34B | -5.22% | 0.00% |
SITE | 49.05% | $5.52B | -26.68% | 0.00% |
SLAB | 48.15% | $3.79B | -13.44% | 0.00% |
ROKU | 47.73% | $10.43B | +14.79% | 0.00% |
IOVA | 47.45% | $1.16B | -74.73% | 0.00% |
SDGR | 47.33% | $1.45B | -20.13% | 0.00% |
AEIS | 47.16% | $3.64B | -2.74% | 0.48% |
PACB | 47.05% | $378.27M | -62.20% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -24.01% | $23.50B | +25.53% | 1.05% |
MO | -17.77% | $96.57B | +35.61% | 6.83% |
PGR | -15.55% | $164.86B | +33.43% | 1.71% |
ED | -14.63% | $38.69B | +21.90% | 2.95% |
GIS | -14.55% | $32.41B | -14.20% | 3.90% |
ACGL | -13.56% | $36.38B | +10.40% | 0.00% |
ALL | -13.43% | $54.44B | +18.46% | 1.83% |
NOC | -12.85% | $74.14B | +12.07% | 1.60% |
PEP | -12.47% | $204.52B | -12.12% | 3.52% |
T | -12.02% | $201.99B | +59.80% | 3.85% |
AJG | -12.02% | $87.99B | +40.23% | 0.71% |
KDP | -11.51% | $47.68B | +13.32% | 2.55% |
CME | -11.45% | $94.61B | +23.82% | 3.89% |
CAG | -11.06% | $12.59B | -9.22% | 5.19% |
DUK | -10.90% | $93.55B | +25.45% | 3.37% |
TSN | -10.57% | $21.91B | +8.55% | 3.09% |
PG | -10.08% | $397.45B | +8.55% | 2.32% |
BTCT | -9.93% | $20.15M | +14.57% | 0.00% |
VHC | -9.89% | $35.77M | +37.68% | 0.00% |
PSQH | -9.83% | $93.55M | -56.05% | 0.00% |